Oncology
1 drug is in development for Neuroendocrine Tumors.
- Companies
- 1
- Clinical trials
- 24
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Neuroendocrine Tumors pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| 177lu-pnt2003 | POINT Biopharma Global Inc. (PNT) |
About this indication
Neuroendocrine Tumors context
Oncology·MeSH: Neuroendocrine Tumors (D018358)
Also known as: Neuroendocrine Tumor
Frequently asked questions
How many drugs are in development for Neuroendocrine Tumors?
BioSniper tracks 1 drug in development for Neuroendocrine Tumors across 1 company.
How many clinical trials target Neuroendocrine Tumors?
There are 24 clinical trials targeting Neuroendocrine Tumors tracked by BioSniper.